World Market for Prescription Generic Drugs, 6th Edition

Apr 1, 2008
250 Pages - Pub ID: KLI1614095
Abstract Table of Contents Search Inside Report Related Reports

Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry. While growth indications are strong, there are challenges for generic companies. In the next two years, consolidation will most likely rise; the sector is expected to be rocked by increased competition from companies in Eastern Europe, India and China, as well as brand name companies seeking to protect their franchises by moving into generics.

Kalorama Information's World Market for Prescription Generic Drugs, 6th Edition is your guide to this formidable and important participant in the complex world of healthcare. Included are market size and forecast revnues for:

  • Allergy and Respiaratory Drugs
  • Analgesics, NAIDS, and Antirheumatic Drugs
  • Anesthesia Drugs
  • Anti-Infectives
  • Cancer Drugs
  • Cardiovascular Drugs
  • Central Nervous System and Psychotherapeutic Drugs
  • Gastrointestinal Drugs
  • Ophthalmic Drugs
This report is the result of primary research and secondary research. Interviews with experts in the generic industry form the basis of this report. Research was conducted from available company reports, trade publications and medical and government databases. Interviews with experts are the source of models.

For each drug segment, the report provides:

  • Estimated Generic Market Size
  • Forecast to 2012
  • Recent ANDA Approvals
  • World and US Market Share
  • Company Profiles
Knowledge of the issues that face the generics industry is essential to understanding the market. The report discusses the following trends:
  • Legislative Issues
  • Big Pharma Tactics
  • Authorized Generics
  • Generic Biologics
  • Medicaid Generic Drug Reimbursement
  • The Elderly
  • Confusion in Generic Names
  • Broadening Generic Horizons
  • International Generic Drug Issues
  • Indian Drug Makers
  • Industry Consolidation
  • New Generic Giants
  • Patent Issues
  • Generic Companies Increasingly Aggressive
  • Patent Reform
  • Generic Growth
  • Generic Statins
  • Cost
  • Generics Improve Compliance
  • Generic Drug Sampling

Marketing executives, business development managers and brand and generic pharmaceutical companies, consultants and investors are among those who will benefit from this report.

Related Reports:

EMR 2014: The Market for Electronic Medical Records
Apr 2, 2014 - KLI5225054 - $3,995.00

Surgical Procedure Volumes: Global Analysis (US, China, Japan, Brazil, UK, Germany, Italy, France, Mexico, Russia)
Feb 22, 2014 - KLI5205473 - $2,995.00

The Worldwide Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement)
Jan 23, 2014 - KLI5192151 - $3,995.00

The World Market for Molecular Diagnostics Six Month Update
Jan 14, 2014 - KLI5181507 - $2,995.00

The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)
Jan 6, 2014 - KLI5177834 - $3,995.00

The World Market for Hematology
Nov 22, 2013 - KLI5156915 - $3,995.00

The World Market for Medical Beds
Nov 8, 2013 - KLI5153655 - $3,995.00

The World Market for Immunoassays
Nov 6, 2013 - KLI5146358 - $3,995.00

The World Market for Infectious Disease Diagnostic Tests
Oct 21, 2013 - KLI5137619 - $3,995.00

The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)
Oct 16, 2013 - KLI5136277 - $3,995.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
Why Epigenomics May Be a Game-Changer in Diagnostics and Pharmaceuticals
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
Kalorama Vaccine Market Research Report Bundle (Vaccines 2012, What's Next in Vaccines, Vaccine Production Markets)
White Paper: The Scourge of Cancer (Incidence by Country, Mechanisms, Growth Factors)
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2014 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
4/19/2014 - 42
SSL
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 5:30am - 6:30pm EST
Fridays: 5:30am - 5:30pm EST